Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael K. Dush
Observed names:
M K Dush,
Michael Dush
Institution:
North Carolina State University
Observed institutions:
National Institutes of Health,
North Carolina State University,
University of California, San Francisco,
Augusta University,
GlaxoSmithKline (United States),
University of Cincinnati,
University of Cincinnati Medical Center,
University of Colorado Denver
show all 8
OpenAlex ID:
A5017289596
Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.
1988
·
M A Frohman
, M K Dush
, et al.
·
Proceedings of the National Academy of Sciences
·
4,579
Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene: presence of a coding region common to animal and bacterial phosphoribosyltransferases that has a variable intron/exon arrangement.
1985
·
M K Dush
, J M Sikela
, et al.
·
Proceedings of the National Academy of Sciences
·
154
PDF
Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2006
·
Wenle Xia
, John Bisi
, et al.
·
Cancer Research
·
150
Analysis of mouse Evx genes: Evx-1 displays graded expression in the primitive streak
1992
·
Michael K. Dush
, Gail R. Martin
·
Developmental Biology
·
139
Comparative anatomy of the human APRT gene and enzyme: nucleotide sequence divergence and conservation of a nonrandom CpG dinucleotide arrangement.
1987
·
T P Broderick
, D A Schaff
, et al.
·
Proceedings of the National Academy of Sciences
·
104
Functional Analysis of a Phosphatidic Acid Binding Domain in Human Raf-1 Kinase
2003
·
Sujoy Ghosh
, Sean Moore
, et al.
·
Journal of Biological Chemistry
·
83
Cloning of a functional human adenine phosphoribosyltransferase (APRT) gene: Identification of a restriction fragment length polymorphism and preliminary analysis of DNAs from APRT-deficient families and cell mutants
1984
·
Peter J. Stambrook
, Michael K. Dush
, et al.
·
Somatic Cell and Molecular Genetics
·
44
Acetylcholinesterase plays a non-neuronal, non-esterase role in organogenesis
2017
·
Melissa A. Pickett
, Michael K. Dush
, et al.
·
Development
·
30
Identification of DNA sequences required for mouse APRT gene expression
1988
·
Michael K. Dush
, Michael R. Briggs
, et al.
·
Nucleic Acids Research
·
29
PDF
Jun N-terminal kinase maintains tissue integrity during cell rearrangement in the gut
2013
·
Michael K. Dush
, Nanette M. Nascone-Yoder
·
Development
·
28
Heterotaxin: A TGF-β Signaling Inhibitor Identified in a Multi-Phenotype Profiling Screen in Xenopus Embryos
2011
·
Michael K. Dush
, Andrew L. McIver
, et al.
·
Chemistry & Biology
·
19
Vangl2 coordinates cell rearrangements during gut elongation
2019
·
Michael K. Dush
, Nanette M. Nascone‐Yoder
·
Developmental Dynamics
·
17
PDF
An Unusual Adenine Phosphoribosyltransferase Pseudogene Is Syntenic with Its Functional Gene and Is Flanked by Highly Polymorphic DNAs
1986
·
M K Dush
, J A Tischfield
, et al.
·
Molecular and Cellular Biology
·
15
Jun N-terminal kinase maintains tissue integrity during cell rearrangement in the gut
2013
·
Michael K. Dush
, Nanette M. Nascone-Yoder
·
Journal of Cell Science
·
7
Single-minded 2 is required for left-right asymmetric stomach morphogenesis
2021
·
Brent H. Wyatt
, Nirav M. Amin
, et al.
·
Development
·
3
PDF
Rare variants in CAPN2 increase risk for isolated hypoplastic left heart syndrome
2023
·
Elizabeth E. Blue
, Janson J. White
, et al.
·
Human Genetics and Genomics Advances
·
2
Data from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
Supplementary Figure S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
PDF
Supplementary Table S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
Supplementary Figure S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
Supplementary Table S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
PDF
Supplementary Figure S3 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
Supplementary Figure S4 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
Supplementary Figure S4 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
PDF
Supplementary Figure S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2023
·
Wenle Xia
, John Bisi
, et al.
Show more works
View as search
Works count:
39
Citation count:
5,403
H-index:
13
I10-index:
13
Year
Topic
Type